Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Common stock and Paid-In Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ 316,328		$ 759,432	$ (3,931)	$ (439,173)
Beginning Balance, Shares at Dec. 31, 2022		53,877,000
Issuance of common stock, net of transaction costs, shares		523,000
Issuance of common stock, net of transaction costs, value	11,310		11,310
Stock issued under Employee Stock Purchase Plan, shares		75,000
Issuance of common stock upon vesting of restricted stock units shares		81,000
Stock issued under employee stock purchase plan, value	1,123		1,123
Exercise of stock options	1,832		1,832
Exercise of stock options, shares		126,000
Stock-based compensation	18,271		18,271
Comprehensive loss	2,226			2,226
Net Income (Loss)	(96,974)				(96,974)
Ending Balance at Jun. 30, 2023	254,116		791,968	(1,705)	(536,147)
Ending Balance, Shares at Jun. 30, 2023		54,682,000
Beginning Balance at Mar. 31, 2023	280,330		768,012	(2,514)	(485,168)
Beginning Balance, Shares at Mar. 31, 2023		53,990,000
Issuance of common stock, net of transaction costs, shares		523,000
Issuance of common stock, net of transaction costs, value	11,310		11,310
Stock issued under Employee Stock Purchase Plan, shares		75,000
Stock issued under employee stock purchase plan, value	1,123		1,123
Exercise of stock options	1,348		1,348
Exercise of stock options, shares		94,000
Stock-based compensation	10,175		10,175
Comprehensive loss	809			809
Net Income (Loss)	(50,979)				(50,979)
Ending Balance at Jun. 30, 2023	254,116		791,968	(1,705)	(536,147)
Ending Balance, Shares at Jun. 30, 2023		54,682,000
Beginning Balance at Dec. 31, 2023	539,106		1,191,831	977	(653,702)
Beginning Balance, Shares at Dec. 31, 2023		68,175,000
Issuance of common stock, net of transaction costs, shares		9,557,000
Issuance of common stock, net of transaction costs, value	378,904		378,904
Stock issued under Employee Stock Purchase Plan, shares		115,000
Issuance of common stock upon vesting of restricted stock units shares		244,000
Stock issued under employee stock purchase plan, value	2,027		2,027
Exercise of stock options	$ 20,484		20,484
Exercise of stock options, shares	1,230,857	1,231,000
Stock-based compensation	$ 32,394		32,394
Comprehensive loss	(1,167)			(1,167)
Net Income (Loss)	(140,985)				(140,985)
Ending Balance at Jun. 30, 2024	830,763		1,625,640	(190)	(794,687)
Ending Balance, Shares at Jun. 30, 2024		79,322,000
Beginning Balance at Mar. 31, 2024	874,933		1,595,415	150	(720,632)
Beginning Balance, Shares at Mar. 31, 2024		78,539,000
Stock issued under Employee Stock Purchase Plan, shares		115,000
Issuance of common stock upon vesting of restricted stock units shares		42,000
Stock issued under employee stock purchase plan, value	2,027		2,027
Exercise of stock options	9,244		9,244
Exercise of stock options, shares		626,000
Stock-based compensation	18,940		18,940
Other	14		14
Comprehensive loss	(340)			(340)
Net Income (Loss)	(74,055)				(74,055)
Ending Balance at Jun. 30, 2024	$ 830,763		$ 1,625,640	$ (190)	$ (794,687)
Ending Balance, Shares at Jun. 30, 2024		79,322,000